Paragraph IV Challenges
✉ Email this page to a colleague
| Tradename | Dosage | Generic Name | NDA | ANDAs Submitted | 180 Day Exclusivity Status | Submissiondate |
|---|---|---|---|---|---|---|
| VOXZOGO | Powder for Injection | vosoritide | 214938 | 1 | 2025-11-19 | |
| TAFINLAR | Capsules | dabrafenib mesylate | 202806 | 1 | 2025-11-13 | |
| TAVNEOS | Capsules | avacopan | 214487 | 3 | 2025-11-13 | |
| LIKMEZ | Oral Suspension | metronidazole | 216755 | 1 | 2025-11-13 | |
| LIVMARLI | Oral Solution | maralixibat chloride | 214662 | 3 | 2025-09-29 | |
| QULIPTA | Tablets | atogepant | 215206 | 6 | 2025-09-29 | |
| MOTRIN | Intravenous | ibuprofen | 020418 | 2 | 2025-08-26 | |
| >Tradename | >Dosage | >Generic Name | >NDA | >ANDAs Submitted | >180 Day Exclusivity Status | >Submissiondate |
